Thailand · Delayed Price · Currency is THB BKK:KLINIQ Statistics
Total Valuation
BKK:KLINIQ has a market cap or net worth of THB 5.78 billion. The enterprise value is 5.74 billion.
| Market Cap | 5.78B |
| Enterprise Value | 5.74B |
Important Dates
The next estimated earnings date is Thursday, May 14, 2026.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | Apr 29, 2026 |
Share Statistics
BKK:KLINIQ has 220.00 million shares outstanding.
| Current Share Class | 220.00M |
| Shares Outstanding | 220.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 65.87% |
| Owned by Institutions (%) | 0.81% |
| Float | 73.90M |
Valuation Ratios
The trailing PE ratio is 15.88 and the forward PE ratio is 14.64. BKK:KLINIQ's PEG ratio is 1.11.
| PE Ratio | 15.88 |
| Forward PE | 14.64 |
| PS Ratio | 1.62 |
| PB Ratio | 3.24 |
| P/TBV Ratio | 3.26 |
| P/FCF Ratio | 16.01 |
| P/OCF Ratio | 8.74 |
| PEG Ratio | 1.11 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.09, with an EV/FCF ratio of 15.93.
| EV / Earnings | 15.79 |
| EV / Sales | 1.61 |
| EV / EBITDA | 7.09 |
| EV / EBIT | 12.03 |
| EV / FCF | 15.93 |
Financial Position
The company has a current ratio of 1.21, with a Debt / Equity ratio of 0.38.
| Current Ratio | 1.21 |
| Quick Ratio | 0.72 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | 0.84 |
| Debt / FCF | 1.88 |
| Interest Coverage | 18.12 |
Financial Efficiency
Return on equity (ROE) is 20.81% and return on invested capital (ROIC) is 22.08%.
| Return on Equity (ROE) | 20.81% |
| Return on Assets (ROA) | 9.24% |
| Return on Invested Capital (ROIC) | 22.08% |
| Return on Capital Employed (ROCE) | 20.58% |
| Weighted Average Cost of Capital (WACC) | 5.34% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.10 |
| Inventory Turnover | 5.36 |
Taxes
In the past 12 months, BKK:KLINIQ has paid 97.00 million in taxes.
| Income Tax | 97.00M |
| Effective Tax Rate | 21.04% |
Stock Price Statistics
The stock price has decreased by -7.89% in the last 52 weeks. The beta is 0.25, so BKK:KLINIQ's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | -7.89% |
| 50-Day Moving Average | 24.37 |
| 200-Day Moving Average | 24.06 |
| Relative Strength Index (RSI) | 63.30 |
| Average Volume (20 Days) | 275,114 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BKK:KLINIQ had revenue of THB 3.56 billion and earned 363.70 million in profits. Earnings per share was 1.65.
| Revenue | 3.56B |
| Gross Profit | 1.80B |
| Operating Income | 477.21M |
| Pretax Income | 461.05M |
| Net Income | 363.70M |
| EBITDA | 662.88M |
| EBIT | 477.21M |
| Earnings Per Share (EPS) | 1.65 |
Balance Sheet
The company has 717.31 million in cash and 677.45 million in debt, with a net cash position of 39.85 million or 0.18 per share.
| Cash & Cash Equivalents | 717.31M |
| Total Debt | 677.45M |
| Net Cash | 39.85M |
| Net Cash Per Share | 0.18 |
| Equity (Book Value) | 1.78B |
| Book Value Per Share | 8.06 |
| Working Capital | 217.59M |
Cash Flow
In the last 12 months, operating cash flow was 660.77 million and capital expenditures -300.15 million, giving a free cash flow of 360.62 million.
| Operating Cash Flow | 660.77M |
| Capital Expenditures | -300.15M |
| Depreciation & Amortization | 185.67M |
| Net Borrowing | -137.36M |
| Free Cash Flow | 360.62M |
| FCF Per Share | 1.64 |
Margins
Gross margin is 50.51%, with operating and profit margins of 13.42% and 10.23%.
| Gross Margin | 50.51% |
| Operating Margin | 13.42% |
| Pretax Margin | 12.96% |
| Profit Margin | 10.23% |
| EBITDA Margin | 18.64% |
| EBIT Margin | 13.42% |
| FCF Margin | 10.14% |
Dividends & Yields
This stock pays an annual dividend of 1.45, which amounts to a dividend yield of 5.52%.
| Dividend Per Share | 1.45 |
| Dividend Yield | 5.52% |
| Dividend Growth (YoY) | 3.57% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 87.71% |
| Buyback Yield | n/a |
| Shareholder Yield | 5.52% |
| Earnings Yield | 6.30% |
| FCF Yield | 6.24% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BKK:KLINIQ has an Altman Z-Score of 3.9 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.9 |
| Piotroski F-Score | 5 |